Search results
Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital...
Nature· 4 days agoIdentifying biomarkers associated with risk of severe COVID-19 disease could inform clinical management. Here, the authors identify a long noncoding RNA associated with severe ...
Insider Selling: Avidity Biosciences, Inc. (NASDAQ:RNA) CFO Sells $2,121,000.00 in Stock
ETF DAILY NEWS· 5 days agoAvidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) CFO Michael F. Maclean sold 75,000 shares of Avidity Biosciences stock in a transaction that occurred on Tuesday, ...
What to know about the new 'FLiRT' COVID variants
Fox News· 1 hour agoAccording to the World Health Organization, the "FLiRT" variants of the SARS-CoV-2 coronavirus have been the dominant forms of the virus circulating...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 2 days ago“We continue to have active conversations with both manufacturers, and the negotiations are...
Blood RNA Biomarkers Identify Bacterial and Biofil | Newswise
Newswise· 4 days agoAbstract Purpose: Secondary opportunistic coinfections are a significant contributor to morbidity and mortality in intensive care unit (ICU) patients
Avidity Biosciences Inc [RNA] Insider Activity: An Update for Investors – Knox Daily
Knox Daily· 3 days agoAs a result of the transaction, LEVIN ARTHUR A now holds 14,830 shares, worth roughly $0.43 million. BofA Securities initiated its Avidity Biosciences Inc [RNA] rating to ...
Explainer-What are the FLiRT COVID variants and are they more contagious? By Reuters
Investing.com· 3 hours agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
Bank of America Predicts up to ~200% Surge for These 2 ‘Strong Buy’ Stocks
TipRanks via Yahoo Finance· 5 days agoNew indicators of a cooling economy eased inflation concerns, driving the S&P 500 to record highs...
Newly identified biomarkers may warn of cancer 7 years before symptoms set in
MedicalNewsToday via AOL· 6 days agoResearchers are investigating the potential of a set of blood biomarkers in predicting the risk of...
Harnessing RNAi: Alnylam’s Path From Lab Discovery to Life-Changing Treatments
SciTechDaily· 1 day agoAlnylam Pharmaceuticals, founded by MIT professors and former postdocs, has developed five...